CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness

Angela Franciska Haczku, Katsuyuki Takeda, Eckard Hamelmann, Joan Loader, Anthony Joetham, Imre Redai, Charles G. Irvin, James J. Lee, Hitoshi Kikutani, Daniel Conrad, Erwin W. Gelfand

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

The effects of an anti-CD23 monoclonal antibody (B3B4) in CD23-deficient and CD23-overexpressing mice were compared in a murine model of allergic sensitization. After sensitization and challenge with OA, mice developed increased serum levels of OA-specific IgE and IgG1 with airway eosinophilia and AHR when compared with nonsensitized animals. Anti-CD23 treatment was studied under two protocols: 10-d OA aerosol exposure and intraperitoneal sensitization followed by aerosol challenge. In both protocols anti-CD23 significantly reduced IgE and IgG1 levels, abolished eosinophilia, and normalized AHR in BALB/c and wild-type CD23(+/+) mice but not in CD23(-/-) mice. These changes were associated with increases in IFN-γ and decreases in IL-4 production, suggesting that CD23 binding may affect not only IgE production but also the Th1/Th2 imbalance during the development of allergic AHR. Absence of CD23 in gene-deficient mice significantly enhanced OA- specific IgE and IgG1 levels, airway eosinophilia, and AHR when compared with CD23(+/+) wild-type littermates after sensitization and airway challenge. Sensitized and challenged CD23 transgenic mice also developed eosinophilic airway inflammation and methacholine hyperresponsiveness. However, the extent of AHR, BAL, and tissue eosinophilia in these animals showed a significant negative correlation with levels of CD23 expression on splenic T and B cells, demonstrating a limiting role of CD23 in the development of allergic AHR.

Original languageEnglish (US)
Pages (from-to)952-960
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume161
Issue number3 I
StatePublished - 2000
Externally publishedYes

Fingerprint

Eosinophilia
Immunoglobulin E
Immunoglobulin G
Aerosols
Dimercaprol
Methacholine Chloride
Interleukin-4
Transgenic Mice
B-Lymphocytes
Monoclonal Antibodies
Inflammation
T-Lymphocytes
Serum
Genes

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Haczku, A. F., Takeda, K., Hamelmann, E., Loader, J., Joetham, A., Redai, I., ... Gelfand, E. W. (2000). CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine, 161(3 I), 952-960.

CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness. / Haczku, Angela Franciska; Takeda, Katsuyuki; Hamelmann, Eckard; Loader, Joan; Joetham, Anthony; Redai, Imre; Irvin, Charles G.; Lee, James J.; Kikutani, Hitoshi; Conrad, Daniel; Gelfand, Erwin W.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 161, No. 3 I, 2000, p. 952-960.

Research output: Contribution to journalArticle

Haczku, AF, Takeda, K, Hamelmann, E, Loader, J, Joetham, A, Redai, I, Irvin, CG, Lee, JJ, Kikutani, H, Conrad, D & Gelfand, EW 2000, 'CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness', American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 3 I, pp. 952-960.
Haczku, Angela Franciska ; Takeda, Katsuyuki ; Hamelmann, Eckard ; Loader, Joan ; Joetham, Anthony ; Redai, Imre ; Irvin, Charles G. ; Lee, James J. ; Kikutani, Hitoshi ; Conrad, Daniel ; Gelfand, Erwin W. / CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness. In: American Journal of Respiratory and Critical Care Medicine. 2000 ; Vol. 161, No. 3 I. pp. 952-960.
@article{fc79b780253c437290502557438401a3,
title = "CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness",
abstract = "The effects of an anti-CD23 monoclonal antibody (B3B4) in CD23-deficient and CD23-overexpressing mice were compared in a murine model of allergic sensitization. After sensitization and challenge with OA, mice developed increased serum levels of OA-specific IgE and IgG1 with airway eosinophilia and AHR when compared with nonsensitized animals. Anti-CD23 treatment was studied under two protocols: 10-d OA aerosol exposure and intraperitoneal sensitization followed by aerosol challenge. In both protocols anti-CD23 significantly reduced IgE and IgG1 levels, abolished eosinophilia, and normalized AHR in BALB/c and wild-type CD23(+/+) mice but not in CD23(-/-) mice. These changes were associated with increases in IFN-γ and decreases in IL-4 production, suggesting that CD23 binding may affect not only IgE production but also the Th1/Th2 imbalance during the development of allergic AHR. Absence of CD23 in gene-deficient mice significantly enhanced OA- specific IgE and IgG1 levels, airway eosinophilia, and AHR when compared with CD23(+/+) wild-type littermates after sensitization and airway challenge. Sensitized and challenged CD23 transgenic mice also developed eosinophilic airway inflammation and methacholine hyperresponsiveness. However, the extent of AHR, BAL, and tissue eosinophilia in these animals showed a significant negative correlation with levels of CD23 expression on splenic T and B cells, demonstrating a limiting role of CD23 in the development of allergic AHR.",
author = "Haczku, {Angela Franciska} and Katsuyuki Takeda and Eckard Hamelmann and Joan Loader and Anthony Joetham and Imre Redai and Irvin, {Charles G.} and Lee, {James J.} and Hitoshi Kikutani and Daniel Conrad and Gelfand, {Erwin W.}",
year = "2000",
language = "English (US)",
volume = "161",
pages = "952--960",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3 I",

}

TY - JOUR

T1 - CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness

AU - Haczku, Angela Franciska

AU - Takeda, Katsuyuki

AU - Hamelmann, Eckard

AU - Loader, Joan

AU - Joetham, Anthony

AU - Redai, Imre

AU - Irvin, Charles G.

AU - Lee, James J.

AU - Kikutani, Hitoshi

AU - Conrad, Daniel

AU - Gelfand, Erwin W.

PY - 2000

Y1 - 2000

N2 - The effects of an anti-CD23 monoclonal antibody (B3B4) in CD23-deficient and CD23-overexpressing mice were compared in a murine model of allergic sensitization. After sensitization and challenge with OA, mice developed increased serum levels of OA-specific IgE and IgG1 with airway eosinophilia and AHR when compared with nonsensitized animals. Anti-CD23 treatment was studied under two protocols: 10-d OA aerosol exposure and intraperitoneal sensitization followed by aerosol challenge. In both protocols anti-CD23 significantly reduced IgE and IgG1 levels, abolished eosinophilia, and normalized AHR in BALB/c and wild-type CD23(+/+) mice but not in CD23(-/-) mice. These changes were associated with increases in IFN-γ and decreases in IL-4 production, suggesting that CD23 binding may affect not only IgE production but also the Th1/Th2 imbalance during the development of allergic AHR. Absence of CD23 in gene-deficient mice significantly enhanced OA- specific IgE and IgG1 levels, airway eosinophilia, and AHR when compared with CD23(+/+) wild-type littermates after sensitization and airway challenge. Sensitized and challenged CD23 transgenic mice also developed eosinophilic airway inflammation and methacholine hyperresponsiveness. However, the extent of AHR, BAL, and tissue eosinophilia in these animals showed a significant negative correlation with levels of CD23 expression on splenic T and B cells, demonstrating a limiting role of CD23 in the development of allergic AHR.

AB - The effects of an anti-CD23 monoclonal antibody (B3B4) in CD23-deficient and CD23-overexpressing mice were compared in a murine model of allergic sensitization. After sensitization and challenge with OA, mice developed increased serum levels of OA-specific IgE and IgG1 with airway eosinophilia and AHR when compared with nonsensitized animals. Anti-CD23 treatment was studied under two protocols: 10-d OA aerosol exposure and intraperitoneal sensitization followed by aerosol challenge. In both protocols anti-CD23 significantly reduced IgE and IgG1 levels, abolished eosinophilia, and normalized AHR in BALB/c and wild-type CD23(+/+) mice but not in CD23(-/-) mice. These changes were associated with increases in IFN-γ and decreases in IL-4 production, suggesting that CD23 binding may affect not only IgE production but also the Th1/Th2 imbalance during the development of allergic AHR. Absence of CD23 in gene-deficient mice significantly enhanced OA- specific IgE and IgG1 levels, airway eosinophilia, and AHR when compared with CD23(+/+) wild-type littermates after sensitization and airway challenge. Sensitized and challenged CD23 transgenic mice also developed eosinophilic airway inflammation and methacholine hyperresponsiveness. However, the extent of AHR, BAL, and tissue eosinophilia in these animals showed a significant negative correlation with levels of CD23 expression on splenic T and B cells, demonstrating a limiting role of CD23 in the development of allergic AHR.

UR - http://www.scopus.com/inward/record.url?scp=17144468527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144468527&partnerID=8YFLogxK

M3 - Article

VL - 161

SP - 952

EP - 960

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3 I

ER -